Tag: Genomics
Latham & Watkins Advises Second Genome in $42.6 Million Series B Financing
News
Second Genome, Inc., a privately-held biopharmaceutical company developing novel medicines through innovative microbiome science, has closed an oversubscribed Series B investment round with $42.6 million in financing.
